Announced Fri, 10 Jul · 11:08 IST
RTA certificate on demat remat requests for June quarter
Compliance View source PDF
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.4%1-day move
₹2540.00
prior close
₹2564.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.0-0.0-0.3-1.4-0.5+0.0+0.4-2.4+1.4————
Up moveDown movePending
AI summary
Mankind Pharma filed the Regulation 74(5) certificate from its Registrar KFin Technologies for the quarter ended June 30, 2026. The certificate confirms that during April 1 to June 30, 2026, no requests were received from shareholders for dematerialisation or rematerialisation of shares. This is a routine quarterly compliance filing under SEBI Depositories Regulations and does not involve any change in capital or shareholding structure.
Likely market impact
Routine compliance filing with no effect on share price, business, or shareholder value.